The European healthtech and medtech sectors in 2024 and 2025 have transitioned into a phase of rigorous professionalisation, where the primary challenge is no longer a scarcity of capital but the successful navigation of complex regulatory, clinical, and reimbursement frameworks. This maturation has necessitated a new class of mentors and advisors, often referred to as "translators", who possess the specialised fluency required to bridge the gap between academic research hosp

In an era of accelerated technological change, the healthcare technology (healthtech) sector stands at a unique and complex intersection. Unlike conventional industries, healthtech operates in a domain where the stakes extend beyond market share to encompass patient safety, clinical efficacy, and systemic trust. The traditional benchmark of success, "product-market fit," is therefore a necessary but fundamentally insufficient measure for a healthtech venture.